Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dentinal tubule lumen and exposed dentin mineral represent the physiological and structural targets for the treatment of dentin hypersensitivity and the prevention of dental decay. Dentinal tubules are microscopic channels, typically 1 to 3 micrometers in diameter, that radiate from the dental pulp to the outer limits of the dentin (StatPearls, 2023). When protective enamel or cementum is lost, these tubules become exposed, allowing external thermal, osmotic, or tactile stimuli to induce rapid fluid shifts within the lumen. This fluid movement activates baroreceptors on pulpal nerve fibers, leading to the sharp, transient pain characteristic of hypersensitivity (Brännström, 1963). The mineral component of the dentin, primarily hydroxyapatite, provides the chemical scaffold for the attachment and precipitation of desensitizing agents. Modern dental therapeutics aim to either seal these tubule orifices to prevent fluid flow or utilize ionic exchange to reduce the excitability of the underlying nerves. Effective management of this target is essential for maintaining oral health and improving the quality of life for patients with tooth sensitivity.
Therapeutic agents target this structure through two primary mechanisms: physical occlusion and nerve desensitization. Occluding agents, such as stannous fluoride, arginine-calcium carbonate, or bioactive glass, react with the dentin mineral to precipitate crystals or polymers that block the tubule lumens, thereby halting the fluid movement described by the hydrodynamic theory (Cummins, 2009; PubMed PMID: 19723428). Alternatively, potassium ions from salts like potassium nitrate diffuse through the tubules to the pulp, where they increase extracellular potassium concentration, depolarizing intradental nerves and inhibiting the transmission of pain signals (Markowitz, 1992; PubMed PMID: 1511880).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dentinal tubule and dentin mineral.